Compare iShares MSCI Taiwan ETF (EWT) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Taiwan ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? iShares MSCI Taiwan ETF trades at $114.31 (market cap $12.74B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares MSCI Taiwan ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Taiwan ETF for 52 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| EWT | RPRX | |
|---|---|---|
Market Cap | $12.74B | $25.27B |
Volume | 8,470,920 | 3,671,183 |
Sector | Broad Market / Factor | Health |
52-Week High | $118.00 | $63.96 |
52-Week Low | $60.03 | $35.44 |
Typical Hold Time | 52 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWT trades at $114.31, down 1.66% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF shows strong exposure to Taiwan's semiconductor sector, particularly TSMC, driving AI-related growth potential. Recent news highlights Taiwan's $20 billion investment in US AI infrastructure and institutional buying interest from Bank of America.
Outlook remains positive due to Taiwan's central role in AI chip manufacturing, though geopolitical risks with China pose significant headwinds. Valuation appears reasonable for tech-focused exposure, but investors must weigh growth potential against regional political uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
